Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Cortecs granted patent for Flustat

Aug. 29, 1997

Cel-Sci reaches supply agreement with American Red Cross

Aug. 26, 1997

Vertex discloses a novel series of ICE inhibitors

Aug. 25, 1997

TNF-alpha inhibitors reported by Centocor

Aug. 21, 1997

Infanrix Hep B approved in all EU countries

Aug. 19, 1997

Twinrix now available for pediatric use

Aug. 18, 1997

IL-1ra tested for corneal transplant

Aug. 7, 1997

Alpha-Beta Technology's Betafectin shows efficacy in phase III trial

Aug. 6, 1997

Procept awarded grant for tuberculosis vaccine research

Aug. 5, 1997

Vertex acquires ICE patent portfolio from Sanofi

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.